Saving lives: long-term morbidity and mortality trials with selective angiotensin receptor blocker therapy.

about

A review of olmesartan medoxomil monotherapy: antihypertensive efficacy similar to that of other angiotensin II receptor blocker/hydrochlorothiazide combinations?

P2860

Q35013827-8D4ADD55-871C-483D-B6E4-54C205537139

P2860

Saving lives: long-term morbidity and mortality trials with selective angiotensin receptor blocker therapy.

Item

http://www.wikidata.org/entity/Q36697579

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

2000年论文

@zh

2000年论文

@zh-cn

name

Saving lives: long-term morbid ...... nsin receptor blocker therapy.

@ast

Saving lives: long-term morbid ...... nsin receptor blocker therapy.

@en

type

Item

label

Saving lives: long-term morbid ...... nsin receptor blocker therapy.

@ast

Saving lives: long-term morbid ...... nsin receptor blocker therapy.

@en

prefLabel

Saving lives: long-term morbid ...... nsin receptor blocker therapy.

@ast

Saving lives: long-term morbid ...... nsin receptor blocker therapy.

@en

P1476

Saving lives: long-term morbid ...... nsin receptor blocker therapy.

@en

P2093

McInnes GT

http://www.w3.org/2001/XMLSchema#string

P2860

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

Long-term potential of angiotensin receptor blockade for cardiovascular protection in hypertension: the VALUE trial. Valsartan Antihypertensive Long-term Use Evaluation.

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.

Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease.

Study on COgnition and Prognosis in the Elderly (SCOPE): baseline characteristics.

Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension.

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

P304

S17-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3317/JRAAS.2000.048

http://www.w3.org/2001/XMLSchema#string

P433

2 Suppl

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2000-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6602108

http://www.w3.org/2001/XMLSchema#string

P698

17199214

http://www.w3.org/2001/XMLSchema#string

Saving lives: long-term morbidity and mortality trials with selective angiotensin receptor blocker therapy.

about

P2860

P2860

Saving lives: long-term morbidity and mortality trials with selective angiotensin receptor blocker therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698